Erenumab for Migraine Prevention in a Patient With MELAS Syndrome
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Headache
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Erenumab for Migraine Prevention in a Patient With Mitochondrial Encephalopathy, Lactate Acidosis, and Stroke-Like Episodes Syndrome: A Case Report
Headache 2021 Apr 01;61(4)694-696, S Naegel, P Burow, D Holle, D Stoevesandt, S Heintz, A Thaele, S Zierz, T KrayaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.